NCT06937905
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06937905
Title Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs) (TARLANEC)
Acronym TARLANEC
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Angers - CHU Angers France Details
Avignon - CH Avignon France Details
Besançon - CHU Besançon France Details
Boulogne - Ambroise Paré Boulogne France Details
Caen - CHU Caen France Details
Caen - CHU Caen France Details
Tours - CHU Chambray-lès-Tours France Details
Dijon - Centre Georges-François Leclerc Dijon France Details
Dijon - CHU Bocage Dijon France Details
Grenoble - CHU Grenoble France Details
Le Mans - CHG Le Mans France Details
Lille - Centre Oscar Lambret Lille France Details
Limoges - CHU Limoges France Details
Limoges - CHU Limoges France Details
Lyon - Centre Léon Bérard Lyon France Details
Lyon - Hôpital Edouard Herriot Lyon France Details
Lyon - Hôpital Privé Jean Mermoz Lyon France Details
Marseille - APHM Marseille France Details
Marseille - Institut Paoli-Calmettes Marseille France Details
Montpellier - CHU Montpellier France Details
Nice - Centre Antoine Lacassagne Nice France Details
Paris - Curie Paris France Details
Paris - Hôpital Cochin Paris France Details
Paris - Saint-Antoine Paris France Details
Paris - Tenon Paris France Details
Bordeaux - CHU Pessac France Details
Bordeaux - CHU Pessac France Details
Lyon - HCL Pierre-Bénite France Details
Poitiers - CHU Poitiers France Details
Reims - CHU Reims France Details
Rennes - CHU Rennes France Details
Rouen - CHU Rouen France Details
Nantes - Hôpital Laennec Saint-Herblain France Details
Nantes - Institut de Cancérologie de l'Ouest Saint-Herblain France Details
Strasbourg - Nouvel Hôpital Civil Strasbourg France Details
Toulon - CHI Toulon France Details
Toulouse - CHU Toulouse France Details
Tours - CHU Tours France Details
Vandoeuvre-lès-Nancy - Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy France Details
Villefranche sur Saône - CH Villefranche-sur-Saône France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field